BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,512,784 | -1.3% | 229,247 | +24.3% | 0.41% | +14.2% |
Q2 2023 | $11,660,590 | +11.6% | 184,503 | -20.5% | 0.36% | +12.9% |
Q1 2023 | $10,447,533 | +6.1% | 232,219 | +3.3% | 0.32% | +5.6% |
Q4 2022 | $9,849,101 | +3.7% | 224,814 | +55.9% | 0.30% | -2.9% |
Q3 2022 | $9,500,000 | +81.5% | 144,177 | +39.1% | 0.31% | +73.2% |
Q2 2022 | $5,235,000 | -47.7% | 103,646 | -33.8% | 0.18% | -27.8% |
Q1 2022 | $10,007,000 | +84.2% | 156,646 | +208.8% | 0.25% | +121.4% |
Q4 2021 | $5,433,000 | +0.1% | 50,725 | -3.9% | 0.11% | +8.7% |
Q3 2021 | $5,428,000 | -0.9% | 52,797 | -15.2% | 0.10% | +1.0% |
Q2 2021 | $5,478,000 | -4.4% | 62,278 | +5.7% | 0.10% | -15.7% |
Q1 2021 | $5,728,000 | -47.8% | 58,907 | -39.8% | 0.12% | -50.8% |
Q4 2020 | $10,966,000 | -8.0% | 97,782 | -23.9% | 0.25% | -39.1% |
Q3 2020 | $11,917,000 | +38.0% | 128,559 | +16.1% | 0.40% | +29.5% |
Q2 2020 | $8,637,000 | – | 110,726 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |